Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-01-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-56396-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832571551891849216 |
|---|---|
| author | Mathieu Ferrari Farhaan Parekh Paul Maciocia Pedro Horna Simon Thomas Andrew K. Sewell Martin Pule |
| author_facet | Mathieu Ferrari Farhaan Parekh Paul Maciocia Pedro Horna Simon Thomas Andrew K. Sewell Martin Pule |
| author_sort | Mathieu Ferrari |
| collection | DOAJ |
| format | Article |
| id | doaj-art-e61fc0ace26f4a13a31820eef9b37399 |
| institution | Kabale University |
| issn | 2041-1723 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Nature Communications |
| spelling | doaj-art-e61fc0ace26f4a13a31820eef9b373992025-02-02T12:31:33ZengNature PortfolioNature Communications2041-17232025-01-011611410.1038/s41467-025-56396-7Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapiesMathieu Ferrari0Farhaan Parekh1Paul Maciocia2Pedro Horna3Simon Thomas4Andrew K. Sewell5Martin Pule6Research Division, Autolus TherapeuticsResearch Division, Autolus TherapeuticsResearch Department of Haematology, University College LondonLaboratory Medicine and Pathology, Mayo ClinicResearch Division, Autolus TherapeuticsDivision of Infection and Immunity, Cardiff University School of MedicineResearch Division, Autolus Therapeuticshttps://doi.org/10.1038/s41467-025-56396-7 |
| spellingShingle | Mathieu Ferrari Farhaan Parekh Paul Maciocia Pedro Horna Simon Thomas Andrew K. Sewell Martin Pule Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies Nature Communications |
| title | Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies |
| title_full | Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies |
| title_fullStr | Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies |
| title_full_unstemmed | Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies |
| title_short | Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies |
| title_sort | reply to oligoclonality of trbc1 and trbc2 in t cell lymphomas as mechanism of primary resistance to trbc directed car t cell therapies |
| url | https://doi.org/10.1038/s41467-025-56396-7 |
| work_keys_str_mv | AT mathieuferrari replytooligoclonalityoftrbc1andtrbc2intcelllymphomasasmechanismofprimaryresistancetotrbcdirectedcartcelltherapies AT farhaanparekh replytooligoclonalityoftrbc1andtrbc2intcelllymphomasasmechanismofprimaryresistancetotrbcdirectedcartcelltherapies AT paulmaciocia replytooligoclonalityoftrbc1andtrbc2intcelllymphomasasmechanismofprimaryresistancetotrbcdirectedcartcelltherapies AT pedrohorna replytooligoclonalityoftrbc1andtrbc2intcelllymphomasasmechanismofprimaryresistancetotrbcdirectedcartcelltherapies AT simonthomas replytooligoclonalityoftrbc1andtrbc2intcelllymphomasasmechanismofprimaryresistancetotrbcdirectedcartcelltherapies AT andrewksewell replytooligoclonalityoftrbc1andtrbc2intcelllymphomasasmechanismofprimaryresistancetotrbcdirectedcartcelltherapies AT martinpule replytooligoclonalityoftrbc1andtrbc2intcelllymphomasasmechanismofprimaryresistancetotrbcdirectedcartcelltherapies |